Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
Zong Sheng Guo(University of Pittsburgh), David L. Bartlett(University of Pittsburgh)
Cited by 92
Related Papers
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
|Molecular Therapy|2018|141
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
|Nature Communications|2018|91
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
|The Lancet Oncology|2023|87
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
|Journal for ImmunoTherapy of Cancer|2020|78